MEDICURE INC (MPH.CA) Stock Price, Quote, News and Overview
TSX-V:MPH - TSX Venture Exchange - CA58469E4085 - Common Stock - Currency: CAD
MPH.CA Quote, Performance and Key Statistics
TSX-V:MPH (3/3/2025, 7:00:00 PM)
0.75
+0.08 (+11.94%)
The current stock price of MPH.CA is 0.75 CAD. In the past month the price decreased by -16.67%. In the past year, price decreased by -47.18%.
MPH.CA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| FRX.CA | FENNEC PHARMACEUTICALS INC | N/A | 270.34M | ||
| EPRX.CA | EUPRAXIA PHARMACEUTICALS INC | N/A | 214.26M | ||
| EDT.CA | SPECTRAL MEDICAL INC | N/A | 202.17M | ||
| TH.CA | THERATECHNOLOGIES INC | N/A | 101.16M | ||
| MSCL.CA | SATELLOS BIOSCIENCE INC | N/A | 84.29M | ||
| ONC.CA | ONCOLYTICS BIOTECH INC | N/A | 79.22M | ||
| MDNA.CA | MEDICENNA THERAPEUTICS CORP | N/A | 77.44M | ||
| COV.CA | COVALON TECHNOLOGIES LTD | 14.18 | 66.08M | ||
| MBX.CA | MICROBIX BIOSYSTEMS INC | 38.5 | 54.80M | ||
| SVA.CA | SERNOVA BIOTHERAPEUTICS INC | N/A | 49.83M | ||
| HBP.CA | HELIX BIOPHARMA CORP | N/A | 46.66M | ||
| HEM.CA | HEMOSTEMIX INC | N/A | 20.78M |
Related stock screener links
About MPH.CA
Company Profile
Medicure, Inc. is a pharmaceutical company, which engages in the research, clinical development, and commercialization of cardiovascular therapeutics. The company is headquartered in Winnipeg, Manitoba and currently employs 25 full-time employees. The company is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company's United States subsidiary, Medicure Pharma Inc. The company also operates Marley Drug Inc. (Marley Drug), a pharmacy subsidiary servicing all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving access to medication for all Americans together with exceptional customer service and free home delivery. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome. The company also develops pyridoxal 5'-phosphate analogues (P5P Analogues), the processes for their preparation, compositions containing P5P Analogues.
Company Info
MEDICURE INC
1250 Waverley Street
Winnipeg MANITOBA R3T 6C6 CA
CEO: Albert D. Friesen
Employees: 38
Company Website: https://www.medicure.com/
Investor Relations: http://www.medicure.com/investors.html
Phone: 12044877412
MEDICURE INC / MPH.CA FAQ
What is the stock price of MEDICURE INC today?
The current stock price of MPH.CA is 0.75 CAD. The price increased by 11.94% in the last trading session.
What is the ticker symbol for MEDICURE INC stock?
The exchange symbol of MEDICURE INC is MPH and it is listed on the TSX Venture Exchange exchange.
On which exchange is MPH.CA stock listed?
MPH.CA stock is listed on the TSX Venture Exchange exchange.
What is MEDICURE INC worth?
MEDICURE INC (MPH.CA) has a market capitalization of 7.83M CAD. This makes MPH.CA a Nano Cap stock.
How many employees does MEDICURE INC have?
MEDICURE INC (MPH.CA) currently has 38 employees.
What are the support and resistance levels for MEDICURE INC (MPH.CA) stock?
MEDICURE INC (MPH.CA) has a resistance level at 0.88. Check the full technical report for a detailed analysis of MPH.CA support and resistance levels.
Should I buy MEDICURE INC (MPH.CA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of MPH.CA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of MPH.CA, evaluating the profitability, health, valuation and growth aspects
- MEDICURE INC (MPH.CA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- MEDICURE INC (MPH.CA) Sales and EPS estimates to see what analysts future expectations are.
- MEDICURE INC (MPH.CA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- MEDICURE INC (MPH.CA) Insider and Institutional Ownership to learn about the owners and their transactions.
- MEDICURE INC (MPH.CA) Stock Chart to make your own analysis
- MEDICURE INC (MPH.CA) Latest news and press-releases to stay up to date.
Does MEDICURE INC (MPH.CA) stock pay dividends?
MPH.CA does not pay a dividend.
When does MEDICURE INC (MPH.CA) report earnings?
MEDICURE INC (MPH.CA) will report earnings on 2025-04-07.
What is the Price/Earnings (PE) ratio of MEDICURE INC (MPH.CA)?
MEDICURE INC (MPH.CA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.19).
MPH.CA Technical Analysis
MPH.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to MPH.CA. MPH.CA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
MPH.CA Financial Highlights
Over the last trailing twelve months MPH.CA reported a non-GAAP Earnings per Share(EPS) of -0.19. The EPS decreased by -289.86% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.14% | ||
| ROE | -10.18% | ||
| Debt/Equity | 0.03 |
MPH.CA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 40% to MPH.CA. The Buy consensus is the average rating of analysts ratings from 8 analysts.